CLINICAL_TRIALS
trial_result
· 2024-01-10
Clinical Trial Update: Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study [Phase 3]
Summary
Phase 3 trial comparing 2-dose vs 3-dose regimens of a Clostridium difficile vaccine has completed with results posted.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Pfizer | Conditions: Clostridium Difficile Associated Disease | Phase 3 | Status: COMPLETED | Results posted: 2024-01-10